In a Wilms tumor, a malignant tumor of the kidney, and in prostate cancer, the PCDHGC3 promoter was found unmethylated, while in breast cancer, hypermethylation of the PCDHGC3 promoter occurs, which leads to suppressed expression [21,22,23,24]. This evidence concerns the gene PCDHGC3 and prostate carcinoma.